Larry Ellison canceled a plan to sell up to 50 million oracle shares. Oracle said no stock was sold under the plan, and he has no other plans to sell any of his Oracle stock. The cancellation removes a large planned sale just as ORCL faced fresh pressure from AI-linked trading.
50 Million Shares, Up to $7.5 Billion
The plan covered up to 50 million Oracle shares, or as much as $7.5 billion at recent pricing. It was originally set to run from From June through October 2026, making the cancellation more than a routine tweak to a trading schedule. For shareholders, that means one large supply overhang is no longer sitting over the stock.
Friday brought another pressure point: Oracle's 2026 restructuring plan was expected to cost about $2.8 billion, roughly $700 million more than previously projected. Much of the increase is tied to employee severance costs, which adds a second layer of cost pressure alongside the company's heavier AI spending. For readers tracking Oracle's capital allocation, the spending and restructuring math is now moving in opposite directions.
Late Sunday Drop in ORCL
About 2% was shaved off Oracle shares in overnight trading Late Sunday, after a broader selloff in AI-linked stocks. Anthropic and OpenAI had called for the industry to pace the development of frontier AI technology, and OpenAI said it is delaying its planned initial public offering until next year. The stock move showed that the cancellation did not by itself override the wider AI trade.
About 5.4% was the size of ORCL's drop last week, despite a strong earnings report. As of Friday, the percentage of shares sold short had risen to 1.7% from 0.9% at the start of the year, a near-doubling that helps explain why the stock can still move sharply on insider-sale news. Jim Cramer said, "Larry's going to jam up the shorts but good with that cancellation of his Oracle sell plan. He's one canny fellow," and the trading setup now leaves Oracle investors weighing a cleaner insider signal against a harder operating backdrop.
Oracle, Shorts, and IPO Pressure
1.7% short interest leaves more room for a squeeze if buying returns, but the stock has already shown how quickly that can fade when AI sentiment weakens. Oracle's next swing will likely depend on whether the market treats the canceled sale as a confidence signal or as one part of a broader AI stock reset. The unresolved pressure point is whether OpenAI's delay and Oracle's rising restructuring bill keep overshadowing the insider news.
